CBOE insiders dump $4.7 M in shares, no buying as stock nears 52‑week high

Over the last year Cboe Global Markets, Inc. (CBOE) recorded six insider sell transactions totaling $4,734,366 and no insider purchases. The resulting buy‑sell ratio of 0.00x falls far beneath the 0.2x benchmark that flags heavy insider selling, a metric that analysts watch closely for potential downside risk. While routine sales tied to equity compensation are common, the concentration of value in a handful of senior executives suggests a more material signal.

The chief operating officer, Christopher A. Isaacson, alone accounted for $2,290,150 in sales, representing roughly 48% of the total insider sell volume. Isaacson executed two identical 5,000‑share sales—one on June 9, 2025 for $1,106,850 and another on September 2, 2025 for $1,183,300. Such sizable disposals from a C‑suite officer are unusual in a period where the stock has appreciated sharply; the price now sits at $368.34, up 44.6% year‑to‑date and just 3% shy of its 52‑week high.

Two directors also contributed materially to the sell side. Edward J. Fitzpatrick and Alexander JR. Matturri each sold shares on February 18, 2026, together moving $1,556,369—about 33% of the aggregate sell amount. Fitzpatrick’s 3,947‑share sale fetched $1,128,329, while Matturri’s 1,500‑share transaction generated $428,040. The coincidence of two director sales on the same day does not meet the three‑insider‑in‑30‑days cluster threshold, yet the combined dollar impact underscores a coordinated reduction of exposure among senior leadership.

The remaining sales were executed by a vice‑president/EVP, Catherine R. Clay, who sold 3,598 shares for $815,235, and an “other C‑suite” insider who disposed of $72,612 worth of stock. Across the twelve‑month window, insider selling was not evenly distributed; the bulk of activity clustered in six months—February 2025 ($4.20 M), August 2024 ($1.52 M), September 2024 ($1.58 M), and May 2025 ($815 k). The February 2025 spike alone exceeded the total value of all other months combined, indicating a period of heightened insider liquidity.

From a market perspective, CBOE’s shares are perched near the top of their trading range, with an RSI of 80 signaling overbought conditions. The stock’s recent daily gain of 1.47% and a market capitalization of $38.5 billion reflect strong investor enthusiasm despite the insider sell‑off. Historically, heavy insider selling in a high‑momentum environment can precede a corrective move, especially when the sales originate from C‑suite executives who possess the most granular view of the company’s outlook. Investors should weigh the material nature of the $4.73 million sell‑side activity against the bullish technical backdrop, monitoring for any further insider disposition that could amplify the signal.

In sum, the absence of any insider buying, the concentration of sales in the COO and two directors, and the stock’s proximity to its 52‑week high together form a mixed picture. While the market remains optimistic, the insider sell pattern warrants close attention as a potential early warning of shifting internal sentiment.